CAM
PGNX

Capstone Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Capstone Asset Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		$279K Sell
41,150
-390
-0.9% -$2.64K 0.01% 1312
2017
Q1 		$392K Buy
+41,540
New +$392K 0.01% 1071